Infex strengthens Board with appointment of Professor Colm Leonard as Non-Executive Director

Alderley Park, Cheshire, U.K. Infex Therapeutics, a leading anti-infectives…


Antimicrobial discovery and drug development - RSC Podcast

How do we develop drugs like antibiotics? How long does it take for such a drug…


Infex’s novel AMR drug candidate MET-X receives FDA QIDP designation

Alderley Park, Cheshire, U.K. Infex Therapeutics, a leading anti-infectives…


Infex enters clinic with lead anti-virulence candidate RESP-X for Pseudomonas aeruginosa

First subject dosed in Phase I study to evaluate safety and tolerability of…


Infex Awarded Biomedical Catalyst Grant For COV-X Project

Alderley Park, Cheshire, U.K - Infex Therapeutics, a leading anti-infectives…


COVID-19 Pandemic Triggers Upsurge in MBL Infections

New research has discovered that the ongoing COVID-19 pandemic has triggered a…